ATPase secretory pathway Ca2+ transporting 1
Senast uppdaterad 18 aug 2020
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Den ATP2C1 gene provides instructions for making a protein called hSPCA1. This protein is an adenosine triphosphate (ATP)-powered calcium pump, which uses energy from ATP molecules to pump charged calcium atoms (calcium ions) across cell membranes. Specifically, the hSPCA1 protein transports calcium ions into a cell structure called the Golgi apparatus, where they are stored until needed. The appropriate storage and release of calcium is essential for many cell activities, including cell growth and division (proliferation), cell movement (migration), and attachment of cells to one another (cell adhesion).
Videoval för GenesVideobibliotek
Normal function
Den ATP2C1 gene provides instructions for making a protein called hSPCA1. This protein is an adenosine triphosphate (ATP)-powered calcium pump, which uses energy from ATP molecules to pump charged calcium atoms (calcium ions) across cell membranes. Specifically, the hSPCA1 protein transports calcium ions into a cell structure called the Golgi apparatus, where they are stored until needed. The appropriate storage and release of calcium is essential for many cell activities, including cell growth and division (proliferation), cell movement (migration), and attachment of cells to one another (cell adhesion).
The hSPCA1 protein also transports manganese ions into the Golgi apparatus. Manganese works with a variety of enzymes and is involved in processing newly formed proteins.
The hSPCA1 protein is present in cells throughout the body. It appears to be particularly important for the normal function of cells called keratinocytes, which are found in the outer layer of the skin (the epidermis). In addition to proliferation and adhesion, calcium regulation in these cells appears to play an important role in maintaining the skin's barrier function, helping to keep foreign invaders such as bacteria out of the body.
Conditions referring to this gene or chromosome
Other names
AT2C1_HUMAN
ATP-dependent Ca(2+) pump PMR1
ATP2C1A
ATPase 2C1
ATPase, Ca(2+)-sequestering
ATPase, Ca++ transporting, type 2C, member 1
BCPM
calcium-transporting ATPase type 2C member 1
HHD
hSPCA1
HUSSY-28
KIAA1347
PMR1
secretory pathway Ca2+/Mn2+ ATPase 1
SPCA1
Related patient information and medicines

Patient information leaflet
Kan jag ta Apixaban och Empagliflozin tillsammans?
It is generally considered safe to take these two medications together. Why this happens Apixaban (a blood thinner) and empagliflozin (a diabetes medication) are processed by different pathways in the body. Apixaban is mainly broken down by specific liver enzymes (CYP3A4) and a transport protein (P-gp), while empagliflozin is processed through a.

Patient information leaflet
Typ 2-diabetesbehandling
Managing typ 2 diabetes Keeping your blood sugar (glucose) well controlled is key to reducing your risk of long-term complications such as heart, kidney or eye problems. Regardless of whether you need medication or which medication you are taking, diet an... These actions include: Stimulating insulin secretion in response till glucose; and.

Patient information leaflet
Kan jag ta Mirabegron och Rivaroxaban tillsammans?
Taking these two medicines together is generally considered sa... Why this happens Mirabegron Mirabegron for urinary symptoms and rivaroxaban Rivaroxaban tablets are processed by different pathways in the body. Mirabegron is primarily broken down by enzymes called CYP3A4 and CYP2D6, while rivaroxaban is processed by CYP3A4 and a transport protein.

Patient information leaflet
Screening för Downs syndrom
See the separate leaflet called Downs syndrom for. What increases your chance of having a baby with Down's syndrome. Anyone can have a baby with Down's syndrome but a woman's chance increases as she becomes older. Large studies have been carried out to look at the chance of Down's syndrome related to a mother's age and have shown that: A.

Patient information leaflet
Kan jag ta Alogliptin och Apixaban tillsammans?
It is generally considered safe to take these two medications together. Why this happens Alogliptin (a diabetes medication) and apixaban (a blood thinner) are processed by different pathways in the body. Alogliptin is primarily excreted unchanged by the kidneys, while apixaban is processed by specific liver enzymes (CYP3A4) and a transport protein.

Patient information leaflet
Kan jag ta Allopurinol och Rosuvastatin tillsammans?
However, both drugs can rarely affect the liver or cause muscle-related side effects, so it is important to be aware of any new symptoms. Why this happens Allopurinol (used for gout) and rosuvastatin (a statin for cholesterol) are processed by different pathways in the body. Allopurinol is primarily cleared by the kidneys, while rosuvastatin is.
Vidare läsning och referenser
- ATPase secretory pathway Ca2+ transporting 1; MedlinePlus, National Library of Medicine.
- Behne MJ, Tu CL, Aronchik I, Epstein E, Bench G, Bikle DD, Pozzan T, Mauro TM. Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores. J Invest Dermatol. 2003 Oct;121(4):688-94. doi: 10.1046/j.1523-1747.2003.12528.x.
- Dobson-Stone C, Fairclough R, Dunne E, Brown J, Dissanayake M, Munro CS, Strachan T, Burge S, Sudbrak R, Monaco AP, Hovnanian A. Hailey-Hailey disease: molecular and clinical characterization of novel mutations in the ATP2C1 gene. J Invest Dermatol. 2002 Feb;118(2):338-43. doi: 10.1046/j.0022-202x.2001.01675.x.
- Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, Ogawa H, Ikeda S, Mauro T, Epstein EH Jr. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 2000 Jan;24(1):61-5. doi: 10.1038/71701.
- Missiaen L, Dode L, Vanoevelen J, Raeymaekers L, Wuytack F. Calcium in the Golgi apparatus. Cell Calcium. 2007 May;41(5):405-16. doi: 10.1016/j.ceca.2006.11.001. Epub 2006 Nov 30.
- Missiaen L, Raeymaekers L, Dode L, Vanoevelen J, Van Baelen K, Parys JB, Callewaert G, De Smedt H, Segaert S, Wuytack F. SPCA1 pumps and Hailey-Hailey disease. Biochem Biophys Res Commun. 2004 Oct 1;322(4):1204-13. doi: 10.1016/j.bbrc.2004.07.128.
- Sudbrak R, Brown J, Dobson-Stone C, Carter S, Ramser J, White J, Healy E, Dissanayake M, Larregue M, Perrussel M, Lehrach H, Munro CS, Strachan T, Burge S, Hovnanian A, Monaco AP. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet. 2000 Apr 12;9(7):1131-40. doi: 10.1093/hmg/9.7.1131.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
18 aug 2020 | Senaste versionen
1 May 2013 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

